Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease
Feixiong Cheng, Fei Wang, Jian Tang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101379-101379
Open Access | Times Cited: 18

Showing 18 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 129
DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer’s disease
Victor O. K. Li, Yang Han, Tushar Kaistha, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease
Yunxiao Ren, Andrew A. Pieper, Feixiong Cheng
Neurotherapeutics (2025), pp. e00553-e00553
Open Access | Times Cited: 1
Artificial Intelligence for Drug Discovery: An Update and Future Prospects
Harrison Howell, Jeremy McGale, Aurélie Choucair, et al.
Seminars in Nuclear Medicine (2025)
Closed Access | Times Cited: 1
Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease
Yunguang Qiu, Yuan Hou, Dhruv Gohel, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114128-114128
Open Access | Times Cited: 7
A Deep Subgrouping Framework for Precision Drug Repurposing via Emulating Clinical Trials on Real-world Patient Data
Seungyeon Lee, Ruoqi Liu, Feixiong Cheng, et al.
(2025), pp. 2347-2358
Open Access
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease
Lijun Dou, Zhenxing Xu, Jielin Xu, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
How to advance the pharmacological management of cognitive impairment in Parkinson's disease
Carla Abdelnour, Lucy L. Gibson, Lucia Batzu, et al.
Journal of Parkinson s Disease (2025)
Open Access
Drug repurposing for Alzheimer’s disease and other neurodegenerative disorders
Jeffrey L. Cummings, Yadi Zhou, Alexandra Stone, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Harnessing omics data for drug discovery and development in ovarian aging
Fengyu Zhang, Ming Zhu, Yi Chen, et al.
Human Reproduction Update (2025)
Closed Access
Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer’s Disease
Justyna Pokrzyk, Agnieszka Kulczynska‐Przybik, Ewa M. Guzik-Makaruk, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1935-1935
Open Access
Instruction multi-constraint molecular generation using a teacher-student large language model
Peng Zhou, Jianmin Wang, Chunyan Li, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
Recent advances in the potential of Phyllanthus emblica L. and its related foods for combating metabolic diseases through methylglyoxal trapping
Shengyi Chen, I‐Chen Chiang, Yingying Chen, et al.
Food Research International (2024) Vol. 194, pp. 114907-114907
Closed Access | Times Cited: 2
Use of Artificial Intelligence in Imaging Dementia
Manal Aljuhani, Azhaar Ashraf, Paul Edison
Cells (2024) Vol. 13, Iss. 23, pp. 1965-1965
Open Access | Times Cited: 2
Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target
Nidhi Puranik, Minseok Song
Molecules (2024) Vol. 29, Iss. 23, pp. 5744-5744
Open Access | Times Cited: 2
DeepDrug: An Expert-led Domain-specific AI-Driven Drug-Repurposing Mechanism for Selecting the Lead Combination of Drugs for Alzheimer’s Disease
Victor O. K. Li, Yang Han, Tushar Kaistha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Advancing Alzheimer's Disease Detection With Big Data and Machine Learning
Shanthi Mahesh, Radhe Mohan
Advances in bioinformatics and biomedical engineering book series (2024), pp. 241-264
Closed Access | Times Cited: 1
Letter to the Editor: “AI and ML in Alzheimer's disease: Transforming early detection and drug development”
Senthamil Selvi Poongavanam, Archana Behera, Mukesh Kumar Dharmalingam Jothinathan
Brain and Spine (2024) Vol. 4, pp. 102847-102847
Open Access
Learning good therapeutic targets in ALS, neurodegeneration, using observational studies
Mohammadali Alidoost, Jeremy Huang, Georgia Dermentzaki, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top